Journal ArticleDOI
Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition).
Terese T. Horlocker,Denise J. Wedel,John C. Rowlingson,F. Kayser Enneking,Sandra L. Kopp,Honorio T. Benzon,David L. Brown,John A. Heit,Michael F. Mulroy,Richard W. Rosenquist,Michael Tryba,Chun-Su Yuan +11 more
Reads0
Chats0
TLDR
The ASRA consensus statements represent the collective experience of recognized experts in the field of neuraxial anesthesia and anticoagulation and are based on case reports, clinical series, pharmacology, hematology, and risk factors for surgical bleeding.About:
This article is published in Regional Anesthesia and Pain Medicine.The article was published on 2010-01-01. It has received 1319 citations till now. The article focuses on the topics: Neuraxial blockade & Anesthesiology.read more
Citations
More filters
Journal ArticleDOI
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Catherine M Otto,Rick A. Nishimura,Robert O. Bonow,Blase A. Carabello,John P. Erwin,Federico Gentile,Hani Jneid,Eric V. Krieger,Michael Mack,Christopher J. McLeod,Patrick T. O'Gara,Vera H. Rigolin,Thoralf M. Sundt,Annemarie Thompson,Christopher Toly +14 more
Journal ArticleDOI
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
Gary H. Lyman,Gary H. Lyman,Kari Bohlke,Alok A. Khorana,Nicole M. Kuderer,Agnes Y.Y. Lee,Juan I. Arcelus,Edward P. Balaban,Jeffrey M. Clarke,Christopher R. Flowers,Charles W. Francis,Leigh E. Gates,Ajay K. Kakkar,Nigel S. Key,Mark Levine,Howard A. Liebman,Margaret A. Tempero,Sandra L. Wong,Mark R. Somerfield,Anna Falanga +19 more
TL;DR: Current recommendations about the prophylaxis and treatment of venous thromboembolism (VTE) in patients with cancer and oncology professionals should educate patients about the signs and symptoms of VTE.
Journal ArticleDOI
Editor's Choice - Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS).
A.R. Naylor,Jean-Baptiste Ricco,G.J. de Borst,Sebastian Debus,J. De Haro,Alison Halliday,George Hamilton,J. Kakisis,Stavros K. Kakkos,Sandro Lepidi,Hugh S. Markus,Dominick J. H. McCabe,Joy Roy,Henrik Sillesen,J.C. van den Berg,Frank Vermassen,Philippe Kolh,Nabil Chakfe,Robert J. Hinchliffe,Igor Koncar,Jes S. Lindholt,M. Vega de Céniga,Fabio Verzini,J. Archie,S. Bellmunt,Arindam Chaudhuri,Mark J.W. Koelemay,A.-K. Lindahl,F. Padberg,Maarit Venermo +29 more
TL;DR: Management of Atherosclerotic Carotid and Vertebral Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS) is published.
Journal ArticleDOI
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key,Alok A. Khorana,Nicole M. Kuderer,Kari Bohlke,Agnes Y. Lee,Juan I. Arcelus,Sandra L. Wong,Edward P. Balaban,Christopher R. Flowers,Charles W. Francis,Leigh E. Gates,Ajay K. Kakkar,Mark Levine,Howard A. Liebman,Margaret A. Tempero,Gary H. Lyman,Anna Falanga +16 more
TL;DR: An Expert Panel convened an Expert Panel to review the evidence and revise previous recommendations as needed to provide updated recommendations about prophylaxis and treatment of venous thromboembolism (VTE) in patients with cancer.
Journal ArticleDOI
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
L. David Hillis,Peter K. Smith,John A. Bittl,Charles R. Bridges,John G. Byrne,Joaquin E. Cigarroa,Verdi J. DiSesa,Loren F. Hiratzka,Adolph M. Hutter,Michael E. Jessen,Ellen C. Keeley,Stephen J. Lahey,Richard A. Lange,Martin J. London,Michael J. Mack,Manesh R. Patel,John D. Puskas,Joseph F. Sabik,Ola A. Selnes,David M. Shahian,Jeffrey C. Trost,Michael D. Winniford,Alice K. Jacobs,Jeffrey L. Anderson,Nancy M. Albert,Mark A. Creager,Steven M. Ettinger,Robert A. Guyton,Jonathan L. Halperin,Judith S. Hochman,Frederick G. Kushner,E. Magnus Ohman,William G. Stevenson,Clyde W. Yancy +33 more
TL;DR: The current and former chairs and vice-chairs of the FACC are: David Hillis, MD, FACC, Chair, Peter K. Smith,MD, F ACC, Vice Chair*, and Ola Selnes, PhD, PhD.
References
More filters
Journal ArticleDOI
A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group
TL;DR: Ebb 761 was safe and appears capable of stabilizing and, in a substantial number of cases, improving the cognitive performance and the social functioning of demented patients for 6 months to 1 year.
Journal ArticleDOI
Oral anticoagulant drugs.
TL;DR: The vitamin K-antagonist drugs were reviewed in the Journal in the early 1970s and their safety has been improved for a number of indications without compromising efficacy, through the use of a lower degree of anticoagulation than formerly in North America.
Journal ArticleDOI
Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
Nirmala Raghavan,Charles Frost,Zhigang Yu,Kan He,Haiying Zhang,W. Griffith Humphreys,Donald J. P. Pinto,Shiang-Yuan Chen,Samuel J. Bonacorsi,Pancras C. Wong,Donglu Zhang +10 more
TL;DR: Apixaban is an orally bioavailable inhibitor of factor Xa with elimination pathways that include metabolism and renal excretion with no serious adverse events or discontinuations due to adverse effects.
Journal ArticleDOI
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.
TL;DR: The mechanism of action of heparin, its pharmacokinetics, anticoagulant effects, and labo- ratory monitoring will be reviewed and the potential of a new class ofheparins, the low molecular weight heparins (LMWHs) will be discussed and their biophysical, pharmacokinetic, antithrombotic, and hemorrhagic properties will be compared with stan- dard hepar in.
Journal ArticleDOI
Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia
TL;DR: The presence of a "true" syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome) in preeclampsia is associated with poor maternal-perinatal outcome.